Akorn, Inc. (AKRN) And Serum Institute of India, Ltd. Announce The Signing Of An Exclusive Drug Development And Distribution Agreement For Oncology And Other Injectable Products
10/19/2005 5:11:50 PM
Akorn, Inc. (OTCBB:AKRN.OB) and Serum Institute of India, Ltd. (Serum) the world's fifth largest vaccine manufacturer, today announced an exclusive drug development and distribution agreement for oncology and other injectable drug products for the United States and Canada.
comments powered by